Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor

The aryl hydrocarbon (Ah) receptor (AHR) mediates many carcinogenic and teratogenic effects of environmentally toxic chemicals such as dioxin. An AHR-deficient (Ahr-/-) mouse line was constructed by homologous recombination in embryonic stem cells. Almost half of the mice died shortly after birth, whereas survivors reached maturity and were fertile. The Ahr-/- mice showed decreased accumulation of lymphocytes in the spleen and lymph nodes, but not in the thymus. The livers of Ahr-/- mice were reduced in size by 50 percent and showed bile duct fibrosis Ahr-/- mice were also nonresponsive with regard to dioxin-mediated induction of genes encoding enzymes that catalyze the metabolism of foreign compounds. Thus, the AHR plays an important role in the development of the liver and the immune system.

[1]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[2]  J. Abel,et al.  Ah receptor in different tissues of C57BL/6J and DBA/2J mice: use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. , 1994, Archives of biochemistry and biophysics.

[3]  L. Poellinger,et al.  Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation , 1994, Molecular and cellular biology.

[4]  H. Li,et al.  Transcriptional activation function of the mouse Ah receptor nuclear translocator. , 1994, The Journal of biological chemistry.

[5]  L. Birnbaum.  Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: implications for policy and future research. , 1994, Environmental health perspectives.

[6]  P. Harper,et al.  Molecular biology of the aromatic hydrocarbon (dioxin) receptor. , 1994, Trends in pharmacological sciences.

[7]  R. Wells,et al.  cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, Cyp1b1. , 1994, DNA and cell biology.

[8]  C. Jefcoate,et al.  Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. , 1994, The Journal of biological chemistry.

[9]  L. Zhang,et al.  Aryl hydrocarbon-induced interactions at multiple DNA elements of diverse sequence--a multicomponent mechanism for activation of cytochrome P4501A1 (CYP1A1) gene transcription. , 1994, Nucleic acids research.

[10]  E. Jabs,et al.  Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.

[11]  O. Gotoh,et al.  Interindividual difference in expression of human Ah receptor and related P450 genes. , 1994, Carcinogenesis.

[12]  L. Birnbaum,et al.  Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. , 1994, Toxicology and applied pharmacology.

[13]  R. Pohjanvirta,et al.  Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-resistant and -susceptible rat strains. , 1994, Toxicology and applied pharmacology.

[14]  D. Nebert.  Drug-metabolizing enzymes in ligand-modulated transcription. , 1994, Biochemical pharmacology.

[15]  M. DeVito,et al.  Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. , 1994, Toxicology and applied pharmacology.

[16]  H. Swanson,et al.  Cloning and expression of a human Ah receptor cDNA. , 1993, Molecular pharmacology.

[17]  H. Swanson,et al.  The AH-receptor: genetics, structure and function. , 1993, Pharmacogenetics.

[18]  S. Rudikoff,et al.  Long‐term thymic reconstitution by peripheral CD4 and CD8 single‐positive lymphocytes , 1993, European journal of immunology.

[19]  Maria Teresa Landi,et al.  Cancer Incidence in a Population Accidentally Exposed to 2,3,7,8‐Tetrachlorodibenzo-para‐dioxin , 1993, Epidemiology.

[20]  M. Gallo,et al.  Receptor mechanisms and dose-response models for the effects of dioxins. , 1993, Environmental health perspectives.

[21]  D. Nebert,et al.  Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. , 1992, DNA and cell biology.

[22]  O. Gotoh,et al.  cDNA cloning and structure of mouse putative Ah receptor. , 1992, Biochemical and biophysical research communications.

[23]  D. Nebert,et al.  Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin. , 1991, Pharmacogenetics.

[24]  K. Dold,et al.  Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. , 1991, Science.

[25]  O. Hankinson,et al.  Cloning of a factor required for activity of the Ah (dioxin) receptor. , 1991, Science.

[26]  J. Miners,et al.  Drug glucuronidation in humans. , 1991, Pharmacology & therapeutics.

[27]  D. Nebert,et al.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.

[28]  M. Capecchi,et al.  Altering the genome by homologous recombination. , 1989, Science.

[29]  D W Nebert,et al.  The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. , 1989, Critical reviews in toxicology.

[30]  F. Gonzalez,et al.  The molecular biology of cytochrome P450s. , 1988, Pharmacological reviews.

[31]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[32]  S. Orrenius,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation. , 1988, Science.

[33]  D. Nebert,et al.  Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues , 1986, Molecular and cellular biology.

[34]  D. Nebert,et al.  Autoregulation plus upstream positive and negative control regions associated with transcriptional activation of the mouse P1(450) gene. , 1985, Nucleic acids research.

[35]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[36]  Joseph F. Williams.  Annual Review of Pharmacology , 1975 .